| Phase I/II Study Of A 5-fraction Hypofractionated Accelerated Radiotherapy Treatment For Low-risk Localised Prostate ... (Medical News Today) |
|
|
UroToday.com - We are in a renaissance in the management of prostate cancer due to two main factors: advancements in technology and research. Standard management options include active surveillance, brachytherapy, external beam radiotherapy, or surgery and each approach is being influenced by research and technology. |